AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...

Coherus, meanwhile, says Yusimry is being offered at an 85% discount to the brand, at $995 for a box of two autoinjectors, which is equivalent to around $13,000 per year versus $85,000 for Humira.

As with other drugs, Humira (adalimumab) can cause side effects, such as headache and injection site reactions. If you are not able to tolerate side effects of Humira, talk with your doctor or ...

Dosage for Humira (adalimumab) may vary based on the condition it’s being used to treat. Also, your doctor may adjust your dosage over the course of your treatment. Be sure to take the Humira ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...